Deep venous stenting in females

Gerry O’Sullivan and Steven Smith

 

Regarding the decision to place a specific venous stent for venous disorders:

 

A) It is a trivial decision, if there is a stenosis it has to be treated.

 

B) There is enough evidence to allow us to treat young women with these devices.

 

C) It is necessary to take into account that this stent will have to perform its functions sometimes for more than 50 years, so it has to be a considered decision.

 

D) It has the same indication if the patient is 70 years old as if she is 35 years old.

 

 

Endovascular treatment of lower limb acute DVT: current trends and future directions

Francesco Siciliano, Edoardo Ronconi, Tommaso Rossi, Federica Fanelli, Miltiadis Krokidis, Pasqualino Sirignano, Michele Rossi & Marcello Andrea Tipaldi

 

Regarding the timing of treatment of deep vein thrombosis, tick the false:

 

A) The definition of ‘optimal timing’ may vary between centres, with some focusing on symptom resolution, while others prioritise prevention of long-term complications, such as post-thrombotic syndrome.

 

B) Difficulties in determining the exact onset of symptoms, especially in cases of chronic or subacute DVT, cannot influence the perceived urgency of intervention - what is urgent is always urgent.

 

C) Remains a topic of debate and ongoing research within the medical community, with clinicians needing to individualise treatment decisions based on patient-specific factors and clinical presentation. Factors such as the presence of complications, risk of thrombus progression and patient preferences should be taken into account when determining the urgency of intervention.

 

D) Studies have shown that the average time from symptom onset to endovascular treatment typically ranges from 7 to 14 days, depending on the severity of symptoms and the presence of associated complications such as pulmonary embolism or limb ischaemia.

 

 

Iliocaval and iliofemoral venous stenting for obstruction secondary to tumor compression

Ahmed K. Aly, Amgad M. Moussa, Olivier Chevallier, Sirish Kishore, Elena Petre, Adie Friedman, Yolanda Bryce, Adrian Gonzalez, Juan Camacho, Ernesto Santos & Fourat Ridouani

 

Regarding the use of stents in patients with venous tumour compression, tick the false one:

 

A) It is important to keep in mind that due to the short survival of these patients, venous intervention in this situation is more focused on improving quality of life.

 

B) Restoration of flow is almost always possible during the procedure, with technical and clinical success rates of 100%.

 

C) The clinical success rate is often lower than the technical success rate and may not be achieved due to multiple factors.

 

D) Patency of iliocaval and iliofemoral venous stents is usually maintained for more than 2 years.

 

 

Send your answers to info@cvirendovascular.org